cloudfront
  • info@reportsandmarkets.com
  • +44-020-3286-9338 (UK) | +1-214-736-7666 (US) | +1-740-994-0111 (US)
  • Sign In
  • Register

Report Detail



OtherGlobal Erectile Dysfunction Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • RnM2474241
  • |
  • 12 December, 2018
  • |
  • Global
  • |
  • 154 pages
  • |
  • GIR (Global Info Research)
  • |
  • Other

Table of Contents

1 Erectile Dysfunction Market Overview
1.1 Product Overview and Scope of Erectile Dysfunction
1.2 Classification of Erectile Dysfunction by Types
1.2.1 Global Erectile Dysfunction Revenue Comparison by Types (2017-2023)
1.2.2 Global Erectile Dysfunction Revenue Market Share by Types in 2017
1.2.3 ED Drugs
1.2.4 ED Devices
1.3 Global Erectile Dysfunction Market by Application
1.3.1 Global Erectile Dysfunction Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Congenital Patients
1.3.3 Pathological Patients
1.4 Global Erectile Dysfunction Market by Regions
1.4.1 Global Erectile Dysfunction Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Erectile Dysfunction Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Erectile Dysfunction Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Erectile Dysfunction Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Erectile Dysfunction Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Erectile Dysfunction Status and Prospect (2013-2023)
1.5 Global Market Size of Erectile Dysfunction (2013-2023)
2 Manufacturers Profiles
2.1 Eli Lilly
2.1.1 Business Overview
2.1.2 Erectile Dysfunction Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eli Lilly Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Erectile Dysfunction Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bayer
2.3.1 Business Overview
2.3.2 Erectile Dysfunction Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bayer Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.4 Boston Scientific
2.4.1 Business Overview
2.4.2 Erectile Dysfunction Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Boston Scientific Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.5 Coloplast
2.5.1 Business Overview
2.5.2 Erectile Dysfunction Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Coloplast Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.6 Apricus Biosciences
2.6.1 Business Overview
2.6.2 Erectile Dysfunction Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Apricus Biosciences Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cristalia Produtos Quimicos Farmaceuticos
2.7.1 Business Overview
2.7.2 Erectile Dysfunction Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cristalia Produtos Quimicos Farmaceuticos Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.8 Dong-A Socio
2.8.1 Business Overview
2.8.2 Erectile Dysfunction Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Dong-A Socio Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.9 Endo Pharmaceuticals
2.9.1 Business Overview
2.9.2 Erectile Dysfunction Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Endo Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.10 Futura Medical
2.10.1 Business Overview
2.10.2 Erectile Dysfunction Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Futura Medical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.11 Meda Pharmaceuticals
2.11.1 Business Overview
2.11.2 Erectile Dysfunction Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Meda Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.12 Promedon
2.12.1 Business Overview
2.12.2 Erectile Dysfunction Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Promedon Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.13 SK Chemical
2.13.1 Business Overview
2.13.2 Erectile Dysfunction Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 SK Chemical Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.14 Teva Pharmaceuticals
2.14.1 Business Overview
2.14.2 Erectile Dysfunction Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Teva Pharmaceuticals Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.15 Vivus
2.15.1 Business Overview
2.15.2 Erectile Dysfunction Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Vivus Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
2.16 Zephyr Surgical Implants (ZSI)
2.16.1 Business Overview
2.16.2 Erectile Dysfunction Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Zephyr Surgical Implants (ZSI) Erectile Dysfunction Revenue, Gross Margin and Market Share (2016-2017)
3 Global Erectile Dysfunction Market Competition, by Players
3.1 Global Erectile Dysfunction Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Erectile Dysfunction Players Market Share
3.2.2 Top 10 Erectile Dysfunction Players Market Share
3.3 Market Competition Trend
4 Global Erectile Dysfunction Market Size by Regions
4.1 Global Erectile Dysfunction Revenue and Market Share by Regions
4.2 North America Erectile Dysfunction Revenue and Growth Rate (2013-2018)
4.3 Europe Erectile Dysfunction Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Erectile Dysfunction Revenue and Growth Rate (2013-2018)
4.5 South America Erectile Dysfunction Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)
5 North America Erectile Dysfunction Revenue by Countries
5.1 North America Erectile Dysfunction Revenue by Countries (2013-2018)
5.2 USA Erectile Dysfunction Revenue and Growth Rate (2013-2018)
5.3 Canada Erectile Dysfunction Revenue and Growth Rate (2013-2018)
5.4 Mexico Erectile Dysfunction Revenue and Growth Rate (2013-2018)
6 Europe Erectile Dysfunction Revenue by Countries
6.1 Europe Erectile Dysfunction Revenue by Countries (2013-2018)
6.2 Germany Erectile Dysfunction Revenue and Growth Rate (2013-2018)
6.3 UK Erectile Dysfunction Revenue and Growth Rate (2013-2018)
6.4 France Erectile Dysfunction Revenue and Growth Rate (2013-2018)
6.5 Russia Erectile Dysfunction Revenue and Growth Rate (2013-2018)
6.6 Italy Erectile Dysfunction Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Erectile Dysfunction Revenue by Countries
7.1 Asia-Pacific Erectile Dysfunction Revenue by Countries (2013-2018)
7.2 China Erectile Dysfunction Revenue and Growth Rate (2013-2018)
7.3 Japan Erectile Dysfunction Revenue and Growth Rate (2013-2018)
7.4 Korea Erectile Dysfunction Revenue and Growth Rate (2013-2018)
7.5 India Erectile Dysfunction Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Erectile Dysfunction Revenue and Growth Rate (2013-2018)
8 South America Erectile Dysfunction Revenue by Countries
8.1 South America Erectile Dysfunction Revenue by Countries (2013-2018)
8.2 Brazil Erectile Dysfunction Revenue and Growth Rate (2013-2018)
8.3 Argentina Erectile Dysfunction Revenue and Growth Rate (2013-2018)
8.4 Colombia Erectile Dysfunction Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Erectile Dysfunction by Countries
9.1 Middle East and Africa Erectile Dysfunction Revenue by Countries (2013-2018)
9.2 Saudi Arabia Erectile Dysfunction Revenue and Growth Rate (2013-2018)
9.3 UAE Erectile Dysfunction Revenue and Growth Rate (2013-2018)
9.4 Egypt Erectile Dysfunction Revenue and Growth Rate (2013-2018)
9.5 Nigeria Erectile Dysfunction Revenue and Growth Rate (2013-2018)
9.6 South Africa Erectile Dysfunction Revenue and Growth Rate (2013-2018)
10 Global Erectile Dysfunction Market Segment by Type
10.1 Global Erectile Dysfunction Revenue and Market Share by Type (2013-2018)
10.2 Global Erectile Dysfunction Market Forecast by Type (2018-2023)
10.3 ED Drugs Revenue Growth Rate (2013-2023)
10.4 ED Devices Revenue Growth Rate (2013-2023)
11 Global Erectile Dysfunction Market Segment by Application
11.1 Global Erectile Dysfunction Revenue Market Share by Application (2013-2018)
11.2 Erectile Dysfunction Market Forecast by Application (2018-2023)
11.3 Congenital Patients Revenue Growth (2013-2018)
11.4 Pathological Patients Revenue Growth (2013-2018)
12 Global Erectile Dysfunction Market Size Forecast (2018-2023)
12.1 Global Erectile Dysfunction Market Size Forecast (2018-2023)
12.2 Global Erectile Dysfunction Market Forecast by Regions (2018-2023)
12.3 North America Erectile Dysfunction Revenue Market Forecast (2018-2023)
12.4 Europe Erectile Dysfunction Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Erectile Dysfunction Revenue Market Forecast (2018-2023)
12.6 South America Erectile Dysfunction Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Erectile Dysfunction Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels.

Scope of the Report:
This report studies the Erectile Dysfunction market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Erectile Dysfunction market by product type and applications/end industries.
The ED drugs segment led the market and accounted for almost 80% of the market share in terms of revenue.
In terms of geography, the Americas dominated the global erectile dysfunction market and is expected to hold close to 50% of the market share.
The global Erectile Dysfunction market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Erectile Dysfunction.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
Eli Lilly
Pfizer
Bayer
Boston Scientific
Coloplast
Apricus Biosciences
Cristalia Produtos Quimicos Farmaceuticos
Dong-A Socio
Endo Pharmaceuticals
Futura Medical
Meda Pharmaceuticals
Promedon
SK Chemical
Teva Pharmaceuticals
Vivus
Zephyr Surgical Implants (ZSI)

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
ED Drugs
ED Devices

Market Segment by Applications, can be divided into
Congenital Patients
Pathological Patients




Summary:
Get latest Market Research Reports on Erectile Dysfunction . Industry analysis & Market Report on Erectile Dysfunction is a syndicated market report, published as Global Erectile Dysfunction Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Erectile Dysfunction market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,480.00
$5,220.00
$6,960.00
2,336.82
3,505.23
4,673.64
3,202.30
4,803.44
6,404.59
421,567.20
632,350.80
843,134.40
230,770.63
346,155.95
461,541.26
Add To Cart Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report